The Correlation of Fibroblast Growth Factor 23 with Cardiac Remodeling in Essential Hypertension with Normal Renal Function
Cardiology · 2022 · 147 (3) · 271-280
DOI: 10.1159/000524764 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiology, online erschienen am 02.05.2022. Verfasst von Jiayu Han und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian, China. Hauptthemen laut MEDLINE: Ventricular Remodeling. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Background
Fibroblast growth factor 23 (FGF23), a glycoprotein-regulating calcium and phosphorus homeostasis, has been linked to cardiovascular diseases. We aimed to evaluate the correlation of FGF23 levels and cardiac remodeling (left atrial [LA] enlargement and left ventricular hypertrophy [LVH]) in essential hypertension (EH) with normal renal function and explore the diagnostic values of FGF23 and B-type natriuretic peptide (BNP) in cardiac remodeling. Methods and Results: We enrolled 40 healthy control subjects (group I) and 146 EH patients (group II). Plasma FGF23 concentration was measured in all subjects. In this study, FGF23 level was significantly higher in group II (660.77 [446.26, 1,001.72]) pg/mL compared with the controls (73.23 [52.92, 103.69]) pg/mL (p < 0.001). Logistic regression analysis revealed that FGF23 was independently correlated to LVH and LA enlargement. Receiver operating characteristic (ROC) curve indicated FGF23 had an optimal cutoff of 834.63 pg/mL for LVH (area under ROC curve [AUC], 0.913; 95% CI: 0.863–0.963) and 497.06 pg/mL for LA enlargement (AUC, 0.694; 95% CI: 0.612–0.768). The DeLong test was performed to compare AUCs of FGF23 and BNP, and the AUC of FGF23 (0.913) was statistically higher compared to AUC of BNP (0.661) (DeLong test: p < 0.001) in the diagnosis of LVH.
Conclusion
Plasma FGF23 level elevated in EH, increased with the progress of cardiac remodeling, and was independently related to LVH and LA enlargement. The diagnostic value of FGF23 in cardiac remodeling, especially for LVH, was superior to BNP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian, China.
- Department of Infection, First Affiliated Hospital of Dalian Medical University, Dalian, China.
- Department of Clinical Laboratory, First Affiliated Hospital of Dalian Medical University, Dalian, China.
Zitieren
APA
Han, J., Yuan, X., Song, W., Cheng, Y., Lu, Y., Zhang, Y., Liu, Y., & Jiang, Y. (2022). The Correlation of Fibroblast Growth Factor 23 with Cardiac Remodeling in Essential Hypertension with Normal Renal Function. Cardiology, 147(3), 271-280. https://doi.org/10.1159/000524764
Vancouver
Han J, Yuan X, Song W, Cheng Y, Lu Y, Zhang Y, et al. The Correlation of Fibroblast Growth Factor 23 with Cardiac Remodeling in Essential Hypertension with Normal Renal Function. Cardiology. 2022;147(3):271-280. doi:10.1159/000524764
BibTeX
@article{Han2022,
author = {Han, Jiayu and Yuan, Xiaoyang and Song, Wei and Cheng, Yunpeng and Lu, Yan and Zhang, Ying and Liu, Yan and Jiang, Yinong},
title = {The Correlation of Fibroblast Growth Factor 23 with Cardiac Remodeling in Essential Hypertension with Normal Renal Function},
journal = {Cardiology},
year = {2022},
volume = {147},
number = {3},
pages = {271--280},
doi = {10.1159/000524764}
}
EUVIMED